Your browser doesn't support javascript.
loading
Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JaK2/STAT3 Signaling.
Akhtar, Sabah; Achkar, Iman W; Siveen, Kodappully S; Kuttikrishnan, Shilpa; Prabhu, Kirti S; Khan, Abdul Q; Ahmed, Eiman I; Sahir, Fairooz; Jerobin, Jayakumar; Raza, Afsheen; Merhi, Maysaloun; Elsabah, Hesham M; Taha, Ruba; Omri, Halima El; Zayed, Hatem; Dermime, Said; Steinhoff, Martin; Uddin, Shahab.
Afiliação
  • Akhtar S; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
  • Achkar IW; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
  • Siveen KS; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
  • Kuttikrishnan S; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
  • Prabhu KS; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
  • Khan AQ; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
  • Ahmed EI; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
  • Sahir F; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
  • Jerobin J; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
  • Raza A; Translational Cancer Research Facility, Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
  • Merhi M; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Elsabah HM; Translational Cancer Research Facility, Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
  • Taha R; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Omri HE; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Zayed H; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Dermime S; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Steinhoff M; Department of Biomedical Sciences, College of Health Sciences, Qatar University, Doha, Qatar.
  • Uddin S; Translational Cancer Research Facility, Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
Front Oncol ; 9: 285, 2019.
Article em En | MEDLINE | ID: mdl-31058086
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Qatar País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Qatar País de publicação: Suíça